To provide a granular and sequential measure of advancing AD pathology, we used trajectory inference methods to compare key DAPs on a common continuous scale, representing increasing Aβ and fibrillar tau pathology (Fig. 5f and Supplementary Fig. 4). Here, MAPT is linked to Alzheimer disease.